Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | KUREKraneShares MSCI All China Health Care Index ETF | VXUSVanguard Total International Stock ETF |
|---|---|---|
| Market | USNYSE Arca | USNasdaq |
| Issuer | KraneShares | Vanguard |
| Asset class | Equity · International | Equity · International |
| Expense ratio | 0.65%Net expense ratio, filed 29 Jul 2025 | 0.05%Expense ratio, filed 27 Feb 2026 |
| Net assets | $71.2MAs of 30 Jun 2026 | $645.9BAs of 31 Jul 2026 |
| Holdings | 63As of 30 Jun 2026 | 8,868As of 31 Jul 2026 |
| 12-month distribution yield | 3.91% | 2.37% |
| Distributions | Yearly$0.7150 in 12 months | Quarterly$1.9850 in 12 months |
| Last price | $18.3020 Oct 2026, 14:53 UTC | $83.7420 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | KURE | VXUS |
|---|---|---|
| KURE | Same fund | 0.3%at least |
| VXUS | 0.3%at least | Same fund |
KURE and VXUS
- Weighted overlap
- 0.3%
- Holdings in common
- 15
- KURE holdings also in VXUS
- 33.3% by count
- VXUS holdings also in KURE
- 0.8% by count
| Holding | Weight in KURE | Weight in VXUS | Overlap | Matched by |
|---|---|---|---|---|
| BeOne Medicines AGBEONE MEDICINES LTD-H COMMON STOCK CH1391448177 | 8.84% | 0.05% | 0.05% | ISIN |
| WUXI BIOLOGICS (CAYMAN) INC.WUXI BIOLOGICS CAYMAN INC COMMON STOCK KYG970081173 | 7.51% | 0.04% | 0.04% | ISIN |
| INNOVENT BIOLOGICS, INC.INNOVENT BIOLOGICS INC COMMON STOCK KYG4818G1010 | 8.80% | 0.04% | 0.04% | ISIN |
| WuXi AppTec Co., Ltd.WUXI APPTEC CO LTD-H COMMON STOCK CNE100003F19 | 3.35% | 0.02% | 0.02% | ISIN |
| CSPC PHARMACEUTICAL GROUP LIMITEDCSPC PHARMACEUTICAL GROUP LT COMMON STOCK HK1093012172 | 3.68% | 0.02% | 0.02% | ISIN |
| Akeso IncAKESO INC COMMON STOCK KYG0146B1032 | 3.72% | 0.02% | 0.02% | ISIN |
| SINO BIOPHARMACEUTICAL LIMITEDSINO BIOPHARMACEUTICAL COMMON STOCK KYG8167W1380 | 3.39% | 0.01% | 0.01% | ISIN |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITEDHANSOH PHARMACEUTICAL GROUP COMMON STOCK KYG549581067 | 2.85% | 0.01% | 0.01% | ISIN |
| 3SBio Inc.3SBIO INC COMMON STOCK KYG8875G1029 | 2.49% | <0.01% | <0.01% | ISIN |
| Sichuan Kelun-Biotech Biopharmaceutical Co LtdSICHUAN KELUN-BIOTECH BIOP-H COMMON STOCK CNE1000062J1 | 1.85% | <0.01% | <0.01% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | KURE | VXUS |
|---|---|---|
| Hong Kong dollar (HKD) | 52.7% | 6.4% |
| Chinese yuan (CNY) | 45.7% | Below the top 12 or none |
| Euro (EUR) | Below the top 12 or none | 19.2% |
| Japanese yen (JPY) | Below the top 12 or none | 15.2% |
| British pound (GBP) | Below the top 12 or none | 8.5% |
| New Taiwan dollar (TWD) | Below the top 12 or none | 8.0% |
| US dollar (USD) | 4.8% | 3.1% |
| Canadian dollar (CAD) | Below the top 12 or none | 7.9% |
| South Korean won (KRW) | Below the top 12 or none | 5.8% |
| Swiss franc (CHF) | Below the top 12 or none | 5.1% |